Mitochondrial heteroplasmy beyond the oocyte bottleneck.

Bottleneck Heteroplasmy Mitochondrial genome Paternal leakage Recombination Somatic segregation

Journal

Seminars in cell & developmental biology
ISSN: 1096-3634
Titre abrégé: Semin Cell Dev Biol
Pays: England
ID NLM: 9607332

Informations de publication

Date de publication:
01 2020
Historique:
received: 04 03 2019
revised: 17 09 2019
accepted: 01 10 2019
pubmed: 16 10 2019
medline: 13 11 2020
entrez: 16 10 2019
Statut: ppublish

Résumé

Inheritance of the mitochondrial genome does not follow the rules of conventional Mendelian genetics. The mitochondrial DNA (mtDNA) is present in many copies per cell and is inherited through the maternal germline. In addition, mutations in the mtDNA will give rise to heteroplasmy, the coexistence of different mtDNA variants within a single cell, whose levels can vary considerably between cells, organs or organisms. The inheritance and subsequent accumulation of deleterious variants are the cause of severe progressive mitochondrial disorders and play a role in many other conditions, including aging, cancer and neurodegenerative disorders. Here, we discuss the processes that give rise to cell-to-cell variability in mtDNA composition, focussing on somatic mtDNA segregation and on less conventional sources of heteroplasmy: non-maternal inheritance and mtDNA recombination. Understanding how mtDNA variants and mutations emerge and evolve within an organism is of crucial importance to prevent and cure mitochondrial disease and can potentially impact more common aging-associated conditions.

Identifiants

pubmed: 31611080
pii: S1084-9521(19)30021-7
doi: 10.1016/j.semcdb.2019.10.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-166

Subventions

Organisme : Wellcome Trust
ID : 105839
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202269/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212219/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1501/2
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Jelle van den Ameele (J)

The Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QN, UK; Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. Electronic address: jv361@cam.ac.uk.

Andy Y Z Li (AYZ)

The Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QN, UK; Department of Genetics, University of Cambridge, Downing Street, Cambridge, CB2 3EH, UK.

Hansong Ma (H)

The Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QN, UK; Department of Genetics, University of Cambridge, Downing Street, Cambridge, CB2 3EH, UK.

Patrick F Chinnery (PF)

Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, CB2 0XY, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH